HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interventional oncology: new options for interstitial treatments and intravascular approaches: superselective TACE using iodized oil for HCC: rationale, technique and outcome.

Abstract
Superselective TACE is defined as TACE from the distal portion of the feeding subsegmental hepatic artery to evoke strong ischemic effects on a small area of the liver, thus avoiding damage to liver function. Lipiodol (iodized oil) is semi-fluid, and it can flow into the surrounding portal venules and hepatic sinusoids through peribiliary plexus (PBP) and the drainage route from the hypervascular HCC. Therefore, the reversed flow from the hepatic sinusoids and portal venules to the peripheral portion of the tumor and daughter nodules can be blocked by Lipiodol injected before a particulate embolus (such as gelatin sponge particles). Common complications of superselective TACE are mild local pain and fever and temporary minimal changes of liver function. Reported CR ratio of definitely hypervascular HCC are around 30-60% by superselective TACE with Lipiodol for hypervascular HCC less than 5 cm. According to a nationwide survey by the Liver Cancer Study Group of Japan (LCSGJ), overall 5-year survival rate was 26% in patients with HCCs not indicated for surgery or RFA (PEI), mainly treated by segmental or subsegmental TACE using Lipiodol. Therefore, this TACE technique should be widely introduced as the first line technique for TACE therapy of HCC.
AuthorsOsamu Matsui, Shiro Miyayama, Jyun-ichiro Sanada, Satoshi Kobayashi, Wataru Khoda, Tetsuya Minami, Kazuto Kozaka, Toshifumi Gabata
JournalJournal of hepato-biliary-pancreatic sciences (J Hepatobiliary Pancreat Sci) Vol. 17 Issue 4 Pg. 407-9 (Jul 2010) ISSN: 1868-6982 [Electronic] Japan
PMID19885639 (Publication Type: Journal Article, Review)
Chemical References
  • Antineoplastic Agents
Topics
  • Antineoplastic Agents (administration & dosage)
  • Carcinoma, Hepatocellular (therapy)
  • Chemoembolization, Therapeutic (methods)
  • Humans
  • Hypertrophy (chemically induced, pathology)
  • Injections, Intravenous
  • Liver (drug effects, pathology)
  • Liver Neoplasms (therapy)
  • Portal Vein
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: